Disclosure of Management Transaction according to the Art. 19 of Regulation (ΕU) No. 596/2014
Peania, 20 March 2023 – Lavipharm S.A. (hereinafter referred to as «Lavipharm»), pursuant to article 19 of Regulation (EU) No. 596/2014, and following a relevant notification, announces that Mr. Vasileios Baloumis, Group CFO: -on 16 March purchased 15,000 common shares of Lavipharm, of a total value...